A bullish research post on OCSL cites director insider buying, a discount to net asset value, and a pending Brookfield-Oaktree transaction as potential catalysts.
OCSL — LONG The author argues OCSL is undervalued at about $12.21 per share versus roughly $16.30 per-share net asset value, a 25% discount, while two directors have bought stock and Oaktree itself bought $100M of new OCSL shares at $17.63. The catalyst is Brookfield's purchase of the remaining 26% of Oaktree, expected to close in the first half of 2026, which could lead to OCSL being taken private or merged at closer to book value, implying 25 to 33% upside. The author says they do not hold OCSL and explicitly warns that a deal is not certain, so the main stated risk is that the speculated transaction does not occur.
If Brookfield decides to take OCSL private or fold it into a bigger fund after the acquisition closes, they'd probably have to pay close to what the shares are actually worth (that $16.30 number). That's 25 to 33% above where it trades right now.
This Reddit post, published February 25, 2026, features u/stockist420 discussing OCSL. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/stockist420 · Tickers: OCSL